Biologics and Cross-Border Trade Drive the Next Phase of Growth in Cold Chain Pharmaceuticals Market
Ottawa, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The global cold chain pharmaceuticals market size is calculated at USD 6.93 billion in 2026 and is expected to reach around USD 9.71 billion by 2035, growing ...
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer Electronic patient self-Reporting of Adverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results